Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Marts 2024

Biotek-snakken — Marts 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
316 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bb
    wrote on sidst redigeret af
    #307

    VKTX er pt oppe med 17% i premaket. Det bliver spændende at følge udviklingen i den i dag 🙂

    1 Reply Last reply
    0
    • 3 Offline
      3 Offline
      3kilofisk
      wrote on sidst redigeret af
      #308

      Lundbeck harvfået godkendt langtidsvirkende medicin mod skizofreni. Er det noget der batter noget?

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #309

        Zai Lab Partner Novocure's Metis Phase 3 Trial Meets Primary Endpoint In Brain Metastases https://www.proinvestor.com/investornyt/1137338/zai-lab-partner-novocures-metis-phase-3-trial-meets-primary-endpoint-in-brain-metastases

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #310

          Aldeyra preps rebound bid for dry-eye hopeful reproxalap https://firstwordpharma.com/story/5841474?from=article

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #311

            Aeovian moves seizure candidate into the clinic, raises $50M
            AV078 is an mTORC1 inhibitor in development for tuberous sclerosis complex (TSC) epilepsy. https://firstwordpharma.com/story/5841451?from=article

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #312

              Akebia gets FDA approval of renal anaemia therapy Vafseo https://firstwordpharma.com/story/5841297?from=article

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #313

                Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimates https://www.proinvestor.com/investornyt/1138130/arcadia-biosciences-rkda-reports-q4-loss-misses-revenue-estimates

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  Kjølstad
                  wrote on sidst redigeret af
                  #314

                  NeuroBo Pharma offentliggør regnskabsresultat 2023 og forventninger til 2024. Lovende data mht. DA-1726 (fedme) og har likvider t.o.m. 2024. Financieringsbehov på sigt. https://www.neurobopharma.com/news-releases/news-release-details/neurobo-pharmaceuticals-reports-year-end-2023-financial-results

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #315

                    Applied Therapeutics Says FDA Extends Review Period Of NDA For Govorestat https://www.proinvestor.com/investornyt/1138140/applied-therapeutics-says-fda-extends-review-period-of-nda-for-govorestat

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #316

                      Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals https://www.proinvestor.com/investornyt/1138230/better-buy-viking-therapeutics-vs-madrigal-pharmaceuticals

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #317

                        Why Viking Therapeutics Stock Was Rocketing Higher This Week https://www.proinvestor.com/investornyt/1138232/why-viking-therapeutics-stock-was-rocketing-higher-this-week

                        1 Reply Last reply
                        0

                        Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                        Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                        With your input, this post could be even better 💗

                        Tilmeld Log ind
                        Svar
                        • Svar som emne
                        Login for at svare
                        • Ældste til nyeste
                        • Nyeste til ældste
                        • Most Votes


                        • Log ind

                        • Har du ikke en konto? Tilmeld

                        • Login or register to search.
                        Powered by NodeBB Contributors
                        • First post
                          Last post
                        0
                        • Kategorier
                        • Seneste
                        • Etiketter
                        • Populære
                        • Verden
                        • Bruger
                        • Grupper